AAAAAA

   
Results: 1-11 |
Results: 11
IFN-GAMMA IN HUMAN CHAGAS-DISEASE - PROTECTION OR PATHOLOGY
Authors: BAHIAOLIVEIRA LMG GOMES JAS ROCHA MOC MOREIRA MCV LEMOS EM LUZ ZMP PEREIRA MES COFFMAN RL DIAS JCP CANCADO JR GAZZINELLI G CORREAOLIVEIRA R
Citation: Lmg. Bahiaoliveira et al., IFN-GAMMA IN HUMAN CHAGAS-DISEASE - PROTECTION OR PATHOLOGY, Brazilian journal of medical and biological research, 31(1), 1998, pp. 127-131
CHAGASIC PATIENTS LACK CD28 EXPRESSION ON MANY OF THEIR CIRCULATING T-LYMPHOCYTES
Authors: DUTRA WO MARTINS OA CANCADO JR PINTODIAS JC BRENER Z GAZZINELLI G CARVALHO JF COLLEY DG
Citation: Wo. Dutra et al., CHAGASIC PATIENTS LACK CD28 EXPRESSION ON MANY OF THEIR CIRCULATING T-LYMPHOCYTES, Scandinavian journal of immunology, 43(1), 1996, pp. 88-93
INFLUENCE OF PARASITE PRESENCE ON THE IMMUNOLOGICAL PROFILE OF PERIPHERAL-BLOOD MONONUCLEAR-CELLS FROM CHAGASIC PATIENTS AFTER SPECIFIC DRUG-THERAPY
Authors: DUTRA WO DALUZ ZMP CANCADO JR PEREIRA ME BRIGIDONUNES RM GALVAO LMC COLLEY DG BRENER Z GAZZINELLI G CARVALHOPARRA JF
Citation: Wo. Dutra et al., INFLUENCE OF PARASITE PRESENCE ON THE IMMUNOLOGICAL PROFILE OF PERIPHERAL-BLOOD MONONUCLEAR-CELLS FROM CHAGASIC PATIENTS AFTER SPECIFIC DRUG-THERAPY, Parasite immunology, 18(11), 1996, pp. 579-585
FLOW-CYTOMETRY, A NEW APPROACH TO DETECT ANTI-LIVE TRYPOMASTIGOTE ANTIBODIES AND MONITOR THE EFFICACY OF SPECIFIC TREATMENT IN HUMAN CHAGAS-DISEASE
Authors: MARTINS OA PEREIRA MES CARVALHO JF CANCADO JR BRENER Z
Citation: Oa. Martins et al., FLOW-CYTOMETRY, A NEW APPROACH TO DETECT ANTI-LIVE TRYPOMASTIGOTE ANTIBODIES AND MONITOR THE EFFICACY OF SPECIFIC TREATMENT IN HUMAN CHAGAS-DISEASE, Clinical and diagnostic laboratory immunology, 2(5), 1995, pp. 569-573
PERIPHERAL-BLOOD MONONUCLEAR-CELLS FRESHLY ISOLATED FROM CHAGASIC PATIENTS DISPLAY A PROFILE CONSISTENT WITH ACTIVATION
Authors: DUTRA WO COFFMAN RL CANCADO JR GOLLOB KJ CORRESOLIVEIRA R BRENER Z COLLEY DG GAZZINELLI G PARRA J
Citation: Wo. Dutra et al., PERIPHERAL-BLOOD MONONUCLEAR-CELLS FRESHLY ISOLATED FROM CHAGASIC PATIENTS DISPLAY A PROFILE CONSISTENT WITH ACTIVATION, The FASEB journal, 9(4), 1995, pp. 782-782
USE OF A 24-KILODALTON TRYPANOSOMA-CRUZI RECOMBINANT PROTEIN TO MONITOR CURE OF HUMAN CHAGAS-DISEASE
Authors: KRAUTZ GM GALVAO LMC CANCADO JR GUEVARAESPINOZA G OUAISSI A KRETTLI AU
Citation: Gm. Krautz et al., USE OF A 24-KILODALTON TRYPANOSOMA-CRUZI RECOMBINANT PROTEIN TO MONITOR CURE OF HUMAN CHAGAS-DISEASE, Journal of clinical microbiology, 33(8), 1995, pp. 2086-2090
ACTIVATED T-LYMPHOCYTES AND B-LYMPHOCYTES IN PERIPHERAL-BLOOD OF PATIENTS WITH CHAGAS-DISEASE
Authors: DUTRA WO MARTINS OA CANCADO JR PINTODIAS JC BRENER Z FREEMAN GL COLLEY DG GAZZINELLI G PARRA JC
Citation: Wo. Dutra et al., ACTIVATED T-LYMPHOCYTES AND B-LYMPHOCYTES IN PERIPHERAL-BLOOD OF PATIENTS WITH CHAGAS-DISEASE, International immunology, 6(4), 1994, pp. 499-506
HUMORAL IMMUNE-RESPONSE TO THE TRYPANOSOMA-CRUZI COMPLEMENT REGULATORY PROTEIN AS AN INDICATOR OF PARASITOLOGICAL CLEARANCE IN HUMAN CHAGAS-DISEASE
Authors: NORRIS KA GALVAO LMC SCHRIMPF JE CANCADO JR KRETTLI AU
Citation: Ka. Norris et al., HUMORAL IMMUNE-RESPONSE TO THE TRYPANOSOMA-CRUZI COMPLEMENT REGULATORY PROTEIN AS AN INDICATOR OF PARASITOLOGICAL CLEARANCE IN HUMAN CHAGAS-DISEASE, Infection and immunity, 62(9), 1994, pp. 4072-4074
AN EXPERIMENTAL AND CLINICAL ASSAY WITH KETOCONAZOLE IN THE TREATMENTOF CHAGAS-DISEASE
Authors: BRENER Z CANCADO JR GALVAO LMD DALUZ ZMP FILARDI LD PEREIRA MES SANTOS LMT CANCADO CB
Citation: Z. Brener et al., AN EXPERIMENTAL AND CLINICAL ASSAY WITH KETOCONAZOLE IN THE TREATMENTOF CHAGAS-DISEASE, Memorias do Instituto Oswaldo Cruz, 88(1), 1993, pp. 149-153
LYTIC ANTIBODY TITER AS A MEANS OF ASSESSING CURE AFTER TREATMENT OF CHAGAS-DISEASE - A 10 YEARS FOLLOW-UP-STUDY
Authors: GALVAO LMC NUNES RMB CANCADO JR BRENER Z KRETTLI AU
Citation: Lmc. Galvao et al., LYTIC ANTIBODY TITER AS A MEANS OF ASSESSING CURE AFTER TREATMENT OF CHAGAS-DISEASE - A 10 YEARS FOLLOW-UP-STUDY, Transactions of the Royal Society of Tropical Medicine and Hygiene, 87(2), 1993, pp. 220-223
USE OF TRYPANOSOMA-CRUZI PURIFIED GLYCOPROTEIN (GP57 51) OR TRYPOMASTIGOTE-SHED ANTIGENS TO ASSESS CURE FOR HUMAN CHAGAS-DISEASE/
Authors: GAZZINELLI RT GALVAO LM KRAUTZ G LIMA APCA CANCADO JR SCHARFSTEIN J KRETTLI AU
Citation: Rt. Gazzinelli et al., USE OF TRYPANOSOMA-CRUZI PURIFIED GLYCOPROTEIN (GP57 51) OR TRYPOMASTIGOTE-SHED ANTIGENS TO ASSESS CURE FOR HUMAN CHAGAS-DISEASE/, The American journal of tropical medicine and hygiene, 49(5), 1993, pp. 625-635
Risultati: 1-11 |